Boston Scientific to appeal order to finish failed $275M merger

Boston Scientific, Channel Medsystems (NYSE:BSX) will appeal a court order requiring it to complete its $275 million purchase of Channel Medsystems.

On Dec. 10. 2019, a Delaware chancery court judge ordered Boston Scientific to finish the merger. In a lawsuit filed in September 2018, Channel claimed that Boston Scientific spiked the deal over a former Channel employee’s scheme to embezzle nearly $3 million from the women’s health company.